These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1371377)

  • 1. The carotenoid halocynthiaxanthin: a novel inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
    Loya S; Kashman Y; Hizi A
    Arch Biochem Biophys; 1992 Mar; 293(2):208-12. PubMed ID: 1371377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors.
    Hizi A; Tal R; Shaharabany M; Currens MJ; Boyd MR; Hughes SH; McMahon JB
    Antimicrob Agents Chemother; 1993 May; 37(5):1037-42. PubMed ID: 7685994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
    Loya S; Rudi A; Tal R; Kashman Y; Loya Y; Hizi A
    Arch Biochem Biophys; 1994 Mar; 309(2):315-22. PubMed ID: 7510944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of reverse transcriptase of human immunodeficiency virus type 1 and chimeric enzymes of human immunodeficiency viruses types 1 and 2 by two novel non-nucleoside inhibitors.
    Rubinek T; McMahon JB; Hizi A
    FEBS Lett; 1994 Aug; 350(2-3):299-303. PubMed ID: 7520874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The catalytic functions of chimeric reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
    Shaharabany M; Hizi A
    J Biol Chem; 1992 Feb; 267(6):3674-8. PubMed ID: 1371274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DNA-dependent and RNA-dependent DNA polymerase activities of the reverse transcriptases of human immunodeficiency viruses types 1 and 2.
    Shaharabany M; Hizi A
    AIDS Res Hum Retroviruses; 1991 Nov; 7(11):883-8. PubMed ID: 1722105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexaprenoid hydroquinones, novel inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
    Loya S; Tal R; Hizi A; Issacs S; Kashman Y; Loya Y
    J Nat Prod; 1993 Dec; 56(12):2120-5. PubMed ID: 7510786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis of the Glu-89 residue in human immunodeficiency virus type 1 (HIV-1) and HIV-2 reverse transcriptases: effects on nucleoside analog resistance.
    Song Q; Yang G; Goff SP; Prasad VR
    J Virol; 1992 Dec; 66(12):7568-71. PubMed ID: 1279207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
    Hizi A; Tal R; Shaharabany M; Loya S
    J Biol Chem; 1991 Apr; 266(10):6230-9. PubMed ID: 1706712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers.
    Held DM; Kissel JD; Thacker SJ; Michalowski D; Saran D; Ji J; Hardy RW; Rossi JJ; Burke DH
    J Virol; 2007 May; 81(10):5375-84. PubMed ID: 17329328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia retroviruses.
    Loya S; Hizi A
    J Biol Chem; 1993 May; 268(13):9323-8. PubMed ID: 7683648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors.
    Dollé V; Fan E; Nguyen CH; Aubertin AM; Kirn A; Andreola ML; Jamieson G; Tarrago-Litvak L; Bisagni E
    J Med Chem; 1995 Nov; 38(23):4679-86. PubMed ID: 7473595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of chimeric human immunodeficiency virus types 1 and 2 reverse transcriptases for structure-function analysis and for mapping susceptibility to nonnucleoside inhibitors.
    Yang G; Song Q; Charles M; Drosopoulos WC; Arnold E; Prasad VR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):326-33. PubMed ID: 8601218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.
    Sevilya Z; Loya S; Adir N; Hizi A
    Nucleic Acids Res; 2003 Mar; 31(5):1481-7. PubMed ID: 12595556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits.
    Sevilya Z; Loya S; Hughes SH; Hizi A
    J Mol Biol; 2001 Aug; 311(5):957-71. PubMed ID: 11531332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
    Ichimura H; Levy JA
    Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The catalytic properties of the reverse transcriptase of the lentivirus equine infectious anemia virus.
    Rubinek T; Loya S; Shaharabany M; Hughes SH; Clark PK; Hizi A
    Eur J Biochem; 1994 Feb; 219(3):977-83. PubMed ID: 7509281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase.
    Buckheit RW; Fliakas-Boltz V; Yeagy-Bargo S; Weislow O; Mayers DL; Boyer PL; Hughes SH; Pan BC; Chu SH; Bader JP
    Virology; 1995 Jun; 210(1):186-93. PubMed ID: 7540784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.